Works matching Wolf, Max


Results: 230
    1
    2
    3
    4

    Max Wolf.

    Published in:
    Mercury, 1994, v. 23, n. 4, p. 27
    By:
    • Tenn, Joseph S.
    Publication type:
    Article
    5
    6

    Prof. Max Wolf.

    Published in:
    Nature, 1933, v. 131, n. 3306, p. 353, doi. 10.1038/131353a0
    By:
    • D. C., A. C.
    Publication type:
    Article
    8
    9

    Max Wolf.

    Published in:
    Astronomische Nachrichten, 1932, v. 247, n. 17, p. 313, doi. 10.1002/asna.19322471702
    By:
    • Vogt, H.
    Publication type:
    Article
    10
    11
    12
    13

    Achter Jupiter-Satellit.

    Published in:
    Astronomische Nachrichten, 1911, v. 188, n. 15, p. 259, doi. 10.1002/asna.19111881505
    By:
    • Wolf, Max
    Publication type:
    Article
    14

    Das Spektrum der Nova Lacertae.

    Published in:
    Astronomische Nachrichten, 1911, v. 187, n. 9, p. 133, doi. 10.1002/asna.19111870903
    By:
    • Wolf, Max
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Var. 6.1909 Ursae majoris.

    Published in:
    Astronomische Nachrichten, 1909, v. 182, n. 11, p. 179, doi. 10.1002/asna.19091821110
    By:
    • Wolf, Max
    Publication type:
    Article
    21
    22

    Über einen Nebelhaufen in Cetus.

    Published in:
    Astronomische Nachrichten, 1909, v. 182, n. 8, p. 131, doi. 10.1002/asna.19091820804
    By:
    • Wolf, Max
    Publication type:
    Article
    23
    24
    25

    Var. 6.1909 Ursae majoris.

    Published in:
    Astronomische Nachrichten, 1909, v. 180, n. 14/15, p. 245, doi. 10.1002/asna.19091801405
    By:
    • Wolf, Max
    Publication type:
    Article
    26

    Über einige Nebelspektren.

    Published in:
    Astronomische Nachrichten, 1909, v. 180, n. 9, p. 151, doi. 10.1002/asna.19091800905
    By:
    • Wolf, Max
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 5, p. 536, doi. 10.1002/ajh.23684
    By:
    • Hertzberg, Mark;
    • Matthews, Jane Palfrey;
    • Stone, Janey Malka;
    • Dubosq, Ming-Celine;
    • Grigg, Andrew;
    • Ellis, David;
    • Benson, Warwick;
    • Browett, Peter;
    • Horvath, Noemi;
    • Januszewicz, Henry;
    • Abdi, Ehtesham;
    • Green, Michael;
    • Bonaventura, Anthony;
    • Marlton, Paula;
    • Cannell, Paul;
    • Wolf, Max
    Publication type:
    Article
    38

    Wolf et al. reply.

    Published in:
    Nature, 2008, v. 451, n. 7182, p. E9, doi. 10.1038/nature06744
    By:
    • Wolf, Max;
    • van Doorn, G. Sander;
    • Leimar, Olof;
    • Weissing, Franz J.
    Publication type:
    Article
    39

    Wolf et al. reply.

    Published in:
    Nature, 2007, v. 450, n. 7167, p. E5, doi. 10.1038/nature06327
    By:
    • Wolf, Max;
    • Sander van Doorn, G.;
    • Leimar, Olof;
    • Weissing, Franz J.
    Publication type:
    Article
    40
    41

    Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 5, p. 786, doi. 10.3109/10428194.2010.547155
    By:
    • Wirth, Andrew;
    • Grigg, Andrew;
    • Wolf, Max;
    • Goldstein, David;
    • Johnson, Carol;
    • Davis, Sidney;
    • Dutu, Gaelle;
    • Kypreos, Poppy;
    • Smith, Carole;
    • Kneebone, Andrew;
    • Herzberg, Mark;
    • Joseph, David;
    • Catalano, John;
    • Roos, Daniel;
    • Stone, Janey;
    • Reynolds, John
    Publication type:
    Article
    42
    43
    44

    Early therapeutic response assessment by 18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.

    Published in:
    Leukemia & Lymphoma, 2007, v. 48, n. 3, p. 596, doi. 10.1080/10428190601099965
    By:
    • Ng, Ashley P.;
    • Wirth, Andrew;
    • Seymour, John F.;
    • Lee, Michael;
    • Hogg, Annette;
    • Januszewicz, Henry;
    • Wolf, Max;
    • Prince, H. Miles;
    • Macmanus, Michael;
    • Hicks, Rodney J.
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Prognostic Markers of Disease Activity in Hodgkin's Disease.

    Published in:
    Leukemia & Lymphoma, 1998, v. 29, n. 3/4, p. 383, doi. 10.3109/10428199809068574
    By:
    • Martinow, Allan J.;
    • Yuen, Kally;
    • Cooper, Ian A.;
    • Matthews, Jane P.;
    • Juneja, Surenda;
    • Wolf, Max;
    • Januszewicz, Henry;
    • Prince, H. Miles
    Publication type:
    Article